Since aprepitant targets two crucial pathways involved in tumorigenesis (PI3K/Akt/mTOR and Wnt), NK-1R antagonists could more easily block escape mechanisms in the HB cells and decrease HB relapse/resistance. Here, MTOR is linked to hemoglobin measurement.